[topsearch__bar__shortcode]

2021 Revenue & Gross Margin Updates: Zomedica Corp. (ZOM) stock Rebounds After hours

[breadcrumb_custom]

Related Topics

Facebook
Twitter
LinkedIn
WhatsApp

On February 25, Zomedica Corp. (ZOM) provided its Q4 and fiscal 2021 revenue and gross margin update. Consequently, the stock rebounded in the after-hours on Friday.

During the regular trading session, the stock suffered a loss of 3.32% at 37.86 million shares. ZOM closed the session at $0.35 per share after fluctuating between $0.34 and $0.38 during the session. Following the announcement, the stock made a comeback in the after-hours to gain a good 15.92%. Hence, ZOM was trading at a value of $0.40 per share at an after-hours volume of 14.48 million shares, on Friday.

The veterinary health company, Zomedica Corp. was founded in 2013. Currently, its 979.89 million outstanding shares trade at a market capitalization of $342.18 million. ZOM stock has added a value of 13.93% year to date, while it subtracted a huge 81.33% last year.

ZOM’s Revenue & Gross Margin

For the fourth quarter and fiscal 2021, the company reported total revenue of $4.1 million, against $0 in the same periods of the previous year. Moreover, ZOM had a gross margin of 73.9% and cash and cash equivalents were $195 million at the end of 2021.

In Q4, PluseVet’s revenue increased by 66% YOY to $4.0 million, against $2.4 million in the year-ago period.

Furthermore, the TRUFORMA® product revenue increased by 22$ to $73,000 in Q4 2021, against $22,500 in the previous quarter.

The company will release its complete Q4 and fiscal 2021 results on March 1, 2022. Additionally, the company’s progress and future outlook will be discussed during its Q1 Virtual Investor Summit on March 8, 2022.

Management Team Additions

Recently, the company announced multiple new additions to its management team, including:

Firstly, on February 15, ZOM announced the appointment of Adrian Lock, Vice President, and General Manager, for leading its sales organization. Mr. Lock is the founding CEO of PluseVet and has been directing the company’s sales activities for over 10 years.

Secondly, on February 07, with more than 25 years of experience, Nicole Westfall joined ZOM as the Vice President, Marketing.

Thirdly, on January 25, with over 30 years of experience, Kristin Domanski was appointed as the Vice President, Human Resources of the company.

And, on January 2, Tony Blair was appointed as the Executive Vice President, Operations, who comes with over 35 years of experience.

In addition, Mr. Evan Saint-Peter has been promoted to the role of Vice President, Technology Innovation.

Leave a Comment

Your email address will not be published. Required fields are marked *

Latest Posts